BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/3/2022 2:36:57 AM | Browse: 483 | Download: 1164
 |
Received |
|
2021-11-18 15:37 |
|
Peer-Review Started |
|
2021-11-18 15:39 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-12-27 02:47 |
|
Revised |
|
2022-01-03 01:53 |
|
Second Decision |
|
2022-01-19 03:57 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-01-20 05:08 |
|
Articles in Press |
|
2022-01-20 05:08 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-02-25 07:33 |
|
Publish the Manuscript Online |
|
2022-03-03 02:36 |
| ISSN |
2220-3141(online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Critical Care Medicine |
| Manuscript Type |
Retrospective Study |
| Article Title |
Retrospective analysis of aspirin's role in the severity of COVID-19 pneumonia
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Maya Gogtay, Yuvaraj Singh, Asha Bullappa and Jeffrey Scott |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Maya Gogtay, MD, Doctor, Doctor, Internal Medicine, Saint Vincent Hospital, 123 Summer street, Worcester, MA 01604, United States. drgogtay@gmail.com |
| Key Words |
COVID-19; Aspirin; Intensive care unit progression; Antiplatelet; Hypercoagulability; Anti-inflammatory |
| Core Tip |
Our study suggests that aspirin has no beneficial effects with regards to progression to intensive care unit (ICU) from the medical floors in COVID-19 positive patients. This study was conducted on the patients presenting during the early phase of the pandemic when there was little evidence on the most beneficial modality of treatment. Over the last 2 years we have learned about the pro-thrombotic nature of COVID-19. Since aspirin is a widely dispensed medication in our adult population, we questioned if its chronic use could have a preventive effect on ICU progression of patients admitted to the medical floors. However, our data analysis suggests that there was no such protective effect. |
| Publish Date |
2022-03-03 02:36 |
| Citation |
Gogtay M, Singh Y, Bullappa A, Scott J. Retrospective analysis of aspirin's role in the severity of COVID-19 pneumonia. World J Crit Care Med 2022; 11(2): 92-101 |
| URL |
https://www.wjgnet.com/2220-3141/full/v11/i2/92.htm |
| DOI |
https://dx.doi.org/10.5492/wjccm.v11.i2.92 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
